Results 181 to 190 of about 9,263,948 (394)

Hodgkin disease‐derived cell lines expressing ubiquitous mitochondrial creatine kinase show growth inhibition by cyclocreatine treatment independent of apoptosis [PDF]

open access: bronze, 2001
Martin Kornacker   +8 more
openalex   +1 more source

CRISPR/Cas9‐edited tumor‐associated immune cells in cancer immunotherapy

open access: yesVIEW, EarlyView.
Abstract Immuno‐oncology represents an emerging field that has significantly transformed tumor therapeutics, with immune cells serving as the cellular foundations of cancer immunotherapy. Due to its high efficiency and sensitivity, CRISPR/Cas9 genome editing is a highly promising technique for precise and rapid gene modification.
Yuhui Ma   +6 more
wiley   +1 more source

UPDATES ON HODGKIN DISEASE

open access: yesHematology, Transfusion and Cell Therapy
Hodgkin Lymphoma (HL) is a B-cell malignancy accounting for approximately 10% of all lymphoma cases and 5% of lymphoma-related mortalities. Incidence increases in younger adults and those above 55-years of age and has a bimodal distribution ...
Valeh Huseynov
doaj  

ALK is not expressed in Hodgkin disease [PDF]

open access: bronze, 2001
Sophie Camilleri‐Bröet   +9 more
openalex   +1 more source

Long‐term survival in a dog with suspected primary nodal plasmacytoma treated with surgical excision

open access: yesVeterinary Record Case Reports, EarlyView.
Abstract An 8‐year‐old Staffordshire bull terrier presented for left submandibular lymphadenopathy. Cytology showed a monomorphic population of mature plasma cells suggestive of plasma cell neoplasia. On physical examination, no other lymphadenomegaly, cutaneous or oral lesions were found.
Celia Figueroa‐González   +4 more
wiley   +1 more source

Advanced hodgkin disease with large mediastinal involvement can be treated with eight cycles of chemotherapy alone after a major response to six cycles of chemotherapy [PDF]

open access: bronze, 2001
Pauline Brice   +9 more
openalex   +1 more source

Pituitary adenoma management and outcomes according to hospital case volume and facility type

open access: yesWorld Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView.
Abstract Objectives This study evaluates the influence of facility volume and type on the treatment and outcomes of pituitary adenoma (PA). Methods The 2004–2016 National Cancer Database was queried for patients with PA receiving definitive treatment. Tumor size represented the largest diameter of the primary tumor.
Khodayar Goshtasbi   +8 more
wiley   +1 more source

Treatment outcomes in classic Hodgkin lymphoma: 5‐year update from the Brazilian Hodgkin Lymphoma Registry

open access: yeseJHaem, 2023
Irene Biasoli   +19 more
doaj   +1 more source

A case of Hodgkin's disease expressing helper/inducer T cell phenotype on Hodgkin and Reed-Sternberg cells.

open access: bronze, 1991
Yutaka Morimura   +5 more
openalex   +2 more sources

A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic model [PDF]

open access: bronze, 2001
Craig H. Moskowitz   +18 more
openalex   +1 more source

Home - About - Disclaimer - Privacy